Family Office Of America (FOFA) Free Cash Flow (2021 - 2026)
Family Office Of America (FOFA) reported Free Cash Flow of $215580.0 for Q1 2026, up 1022.7% on a YoY basis from $19201.9 in Q1 2025, and up 233.73% sequentially from -$161200.0 in Q4 2025.
Family Office Of America (FOFA) Free Cash Flow (2021 - 2026) Analysis & Trends
Family Office Of America (FOFA) has 6 years of Free Cash Flow data on file, last reported at $215580.0 in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 1022.7% year-over-year to $215580.0; the trailing twelve-month figure through Mar 2026 stood at -$23244.0 (up 76.96% YoY), and the FY2025 full-year result was -$262188.0, down 193.37% from the prior year.
- Free Cash Flow improved to $215580.0 in Q1 2026, from -$161200.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $215580.0 in Q1 2026 to a low of -$172198.0 in Q2 2022.
- A 5-year average of -$45349.0 and a median of -$27615.0 in 2024 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow slumped 424.04% in 2024 and jumped 1022.7% in 2026, its largest moves.
- Tracing FOFA's Free Cash Flow over 5 years: stood at -$102094.0 in 2022, then surged by 92.16% to -$8002.0 in 2023, then tumbled by 313.87% to -$33118.0 in 2024, then sank by 386.74% to -$161200.0 in 2025, then soared by 233.73% to $215580.0 in 2026.
- Business Quant data shows FOFA's Free Cash Flow at $215580.0 in Q1 2026, -$161200.0 in Q4 2025, and -$17675.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 215,580.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215,580.00 |
| Mar 31, 2026 | 215,580.00 |
| Dec 31, 2025 | -161,200.00 |
| Dec 31, 2025 | -161,200.00 |
| Sep 30, 2025 | -17,675.00 |
| Sep 30, 2025 | -17,675.00 |
| Jun 30, 2025 | -59,949.00 |
| Jun 30, 2025 | -59,949.00 |
| Mar 31, 2025 | -23,364.00 |
| Mar 31, 2025 | -23,364.00 |
| Dec 31, 2024 | -33,118.00 |
| Dec 31, 2024 | -33,118.00 |
| Sep 30, 2024 | -16,777.00 |
| Sep 30, 2024 | -16,777.00 |
| Jun 30, 2024 | -27,615.00 |
| Jun 30, 2024 | -27,615.00 |
| Mar 31, 2024 | -11,860.00 |
| Mar 31, 2024 | -11,860.00 |
| Dec 31, 2023 | -8,002.00 |
| Dec 31, 2023 | -8,002.00 |